Amarin Corp Plc (AMRN)

[Whalatane]

Gabor so are you saying that more lower risk patients were enrolled in the early years ?

So to bring the study population back into line with the way the study was designed....more higher risk patients had to be enrolled in the later years.

Which has been my opinion all along .

A skeptic like myself would say JZ rushed the numbers in the early years so that he could get the numbers needed to submit for the Anchor indication.
I'd speculate that Dr Bhatt ( lead investigator ) probably stepped in after that and said we need a higher risk profile on the remaining patients recruited ...to comply with over all trial design .


JMO
Kiwi